Neoadjuvant FOLFIRINOX in the Treatment of Locally Advanced Gastric Cancer

NCT03825861 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: FOLFIRINOX

Sponsor

Instituto do Cancer do Estado de São Paulo